Kegoratile Aphane did not flinch when the needle pierced the skin of her right buttock, injecting a yellow-colored drug ...

The fight against HIV/AIDS in South Africa received a historic boost earlier this week as the South African Health Products Regulatory Authority (SAHPRA) announced the registration of lenacapavir.

South Africa has become the first African country - and our medicines regulator the third worldwide – to register the revolutionary twice-a-year anti-HIV jab, lenacapavir. The shot could bring an end ...

The South African government says it could fill the potential gap in the number of doses it will need of the twice-yearly HIV prevention jab to end Aids by 2043 by getting a group of local ...

You’ve probably never heard of Zackie Achmat. Not unless you’re a South African AIDS patient demanding your government’s help to stay alive, or a global pharmaceutical corporation looking to protect ...

South Africa will ensure its HIV-AIDS treatment program doesn’t collapse despite the withdrawal of support from the US, and 659 million rand ($36 million) has already been allocated to extend access ...

Reporting for this story was supported by the Pulitzer Center. Twenty-two-year-old Pamella Jili has seen its impact up close. She grew up in the township, a hot spot in the worst-hit province in South ...

JOHANNESBURG — South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned initial ...

Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S. funding cuts and his own government’s inertia revive old fears. Global ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...